The effects of taxol, methylprednisolone, and 4-aminopyridine in compressive spinal cord injury: A qualitative experimental study

Surgical Neurology

Volumn 46, Issue 4, 1996, Pages 350-357

  Perez Espejo, Miguel A ^d   Haghighi, Siavash S ^c   Adelstein, Edward H ^a   Madsen, Richard ^b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c Center for Neurosciences   (United States)

^d NONE

Author keywords

Behavior; methylprednisolone; somatosensory evoked potentials spinal cord injury; taxol

Indexed keywords

4 AMINOPYRIDINE; AMPICILLIN; BUPRENORPHINE; HALOTHANE; METHYLPREDNISOLONE; PACLITAXEL; PENTOBARBITAL; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; EVOKED SOMATOSENSORY RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MICROTUBULE ASSEMBLY; NONHUMAN; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030273305     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(96)00200-5     Document Type: Article

References (22)

1. 1. Altman DG. Practial statistics for medical research. London: Chapman and Hall, 1991:213-6.
2. 2. Anderson DK. Chemical and cellular mediators in spinal cord injury. J Neurotrauma 1992;9:143-5.
3. 3. Avila J. Microtubule function. Life Sci 1992;50:327-34.
4. 4. Boven E, Venema-Gaberscek E, Erkelens CA, Bissery MC, Pinedo HM. Antitumor activity of texotere (RP 56976, NSC 628503): a new taxol analog in experimental ovarian cancer. Ann Oncol 1993;4:321-4.
5. 5. Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon JC, Marshall LE, Perot PL, Piepmeier J, Sonntag VKH, Wagner FC, Wilberger JE, Winn HR, Young W. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data: results of the Second National Acute Spinal Cord Injury Study. J Neurosurg 1992;76:23-31.
6. 6. Daniel WW. Applied nonparametric statistics. PWS Kent, 2nd ed. Boston: Houghton Mifflin, 1990:241.
7. 7. Derry WB, Wilson L, Jordan MA. Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 1995;34:2203-11.
8. 8. Dunn OJ. Multiple comparisons using rank sums, technometrics. In: Dunn J, ed. Basic statistics: a primer for the biomedical sciences. 6th ed. New York: J. Wiley, 1964:241-52.
9. 9. Dustin P. Microtubules. Berlin: Springer-Verlag, 1984: 210-1.
10. 10. Gale K, Kerasidis H, Wrathall JD. Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment. Exp Neurol 1985;88:123-34.
11. 11. Hall ED, Wolf DL, Braughler JM. Effect of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia: dose-response and time-action analysis. J Neurosurg 1984; 61:124-30.
12. 12. Hayes KC, Blight AR, Potter PJ, Allatt RD, Hsieh JTC, Wolfe DL, Lam S, Hamilton JT. Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury. Paraplegia 1993;31:216-24.
13. 13. Hansebout RR, Blight AR, Fawcett S, Reddy K. 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. J Neurotrauma 1993;10:1-18.
14. 14. McCall JM, Braughler JM, Hall ED. Lipid peroxidation and the role of the oxygen radicals in CNS injury. Acta Anaesthiol Belg 1987;38:373-9.
15. 15. MacRae TH. Toward an understanding of microtubule function and cell organization: an overview. Biochem Cell Biol 1992;70:835-41.
16. 16. Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 1977;47:577-81.
17. 17. Rowinky EK, Cazenave LA, Donehower RC. Taxol: a novel investigational antimicrotubule agent: review. J Natl Cancer Inst 1990;82:1247-59.
18. 18. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979;22:665-7.
19. 19. Taxol. IND 22850. NSC 125973. Clinical brochure. Bethesda: Division of Cancer Treatment. National Cancer Institute, 1992:26-7.
20. 20. Vuorinen VS, Röyttä M. Taxol-induced neuropathy after nerve crush: long-term effects on regenerating axons. Acta Neuropathol (Berl) 1990;79:663-71.
21. 21. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus Brevifolia. J Am Chem Soc 1971; 83:2325-7.
22. 22. Young W, Flamm ES. Effect of high-dose corticosteroid therapy in blood flow, evoked potentials, and extracellular calcium in experimental spinal cord injury. J Neurosurg 1982;57:667-73.